 |
市場調查報告書
商品編碼
1567164
巴斯症候群治療市場：依治療方法、依藥物類別、依給藥途徑、依最終使用者、按地區Barth Syndrome Treatment Market, By Therapeutic Approaches, By Drug Classes, By Route of Administration, By End User, By Geography |
||||||
預計2024年全球巴斯症候群治療市場規模將達1,411億美元，2024年至2031年年複合成長率(CAGR)為13.2%，預計2031年將達3,361.1億美元。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2023年 | 2024年市場規模 | 1411億美元 |
| 實際資料 | 2019年至2023年 | 預測期 | 從2024年到2031年 |
| 預測 2024-2031 年複合年成長率： | 13.20% | 2031年價值預測 | 3361.1億美元 |
近年來，全球巴斯氏症治療市場經歷了顯著成長。巴斯症候群是一種罕見的遺傳性疾病，影響男性骨骼和心肌。此疾病的確切原因是 TAZ 基因突變，影響粒線體功能並導致結構異常。目前這種疾病無法治療方法，治療重點是控制症狀和改善生活品質。開發新型標靶治療的研究活動的開展以及對罕見疾病的認知不斷提高是預計在預測期內推動全球巴特氏症治療市場成長的主要因素。
市場動態：
由於遺傳病患病率上升、政府對罕見疾病研究的支持力度加大以及罕見疾病藥物研發活動的活性化等因素，預計全球巴斯症候群治療市場將在未來八年顯著成長。成長。然而，治療成本上漲、缺乏認證核可藥以及患者診斷困難等挑戰正在限制市場成長。另一方面，基因和細胞療法的發展具有為巴特氏症候群提供新治療選擇的強大潛力，從而在未來幾年為參與者提供利潤豐厚的機會。產業和研究機構繼續努力更好地了解病理學，將進一步擴大治療選擇並促進市場擴張。
本研究的主要特點
本報告詳細分析了全球巴斯症候群治療市場，包括以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
根據公司亮點、產品系列、主要亮點、績效和策略等參數，介紹了全球巴斯綜合症治療市場的主要企業概況。
本研究涵蓋的主要企業包括 Agios Pharmaceuticals, Inc.、Amicus Therapeutics, Inc. 和 Stealth BioTherapeutics Inc.。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
全球巴斯綜合症治療市場報告迎合了該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球巴斯綜合症治療市場的各種策略矩陣，將促進相關人員的決策。
目錄
第1章 研究目的與前提
- 研究目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章市場動態、法規與趨勢分析
- 市場動態
- 影響分析
- 主要亮點
- 監管場景
- 產品發布/核准
- PEST分析
- 波特分析
- 併購場景
第4章全球巴斯症候群治療市場，依治療方法，2024-2031 年（十億美元）
- 酵素替代療法
- 基因治療
- 支持性護理
- 幹細胞療法
- 其他（小分子藥物）
第5章全球巴斯症候群治療市場，依藥物類別，2024-2031 年（十億美元）
- 心磷脂前驅物
- 抗氧化劑
- 免疫調節劑
- 抗生素
- 食品補充品
- 其他
第6章 全球巴斯症候群治療市場，依給藥途徑，2024-2031 年（十億美元）
- 口服
- 靜脈
- 其他（肌內和局部）
第7章 全球巴斯症候群治療市場，依最終使用者分類，2024-2031 年（十億美元）
- 醫院
- 專科診所
- 研究所
- 其他
第8章全球巴斯症候群治療市場，按地區，2019-2031（十億美元）
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太地區
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東地區
- 非洲
- 南非
- 北非
- 中部非洲
第9章 競爭格局
- Amneal Pharmaceuticals
- Boehringer Ingelheim
- Merck & Co.
- Abbott
- B Braun
- Integra LifeSciences
- Johnson & Johnson
- Medtronic
- MicroPort Scientific
- NuVasive
- Orthofix
- Perrigo Company
- Stryker
- Zimmer Biomet
- Eli Lilly and Company
- F. Hoffmann-La Roche
- Mylan
- Stealth BioTherapeutics
- Sanofi
- Pfizer
第10章分析師建議
第11章 參考文獻與調查方法
- 參考
- 調查方法
- 關於出版商
The Global Barth Syndrome Treatment Market is estimated to be valued at USD 141.10 billion in 2024 and is expected to reach USD 336.11 billion by 2031, exhibiting a compound annual growth rate (CAGR) of 13.2% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 141.10 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 13.20% | 2031 Value Projection: | US$ 336.11 Bn |
The global Barth syndrome treatment market has been witnessing significant growth in the recent years. Barth syndrome is a rare genetic disorder affecting skeletal and cardiac muscles in males. The exact cause of the disease is mutations in the TAZ gene affecting mitochondrial function and leading to structural abnormalities. Currently, there is no cure for the condition and treatment focuses on managing symptoms and improving quality of life. Increasing research activities for developing novel targeted therapies and growing awareness about rare diseases are some key factors expected to drive the growth of the global Barth syndrome treatment market during the forecast period.
Market Dynamics:
The global Barth syndrome treatment market is projected to witness notable growth over the next eight years owing to several factors such as rising incidence of genetic disorders, growing government support for rare disease research, and increasing R&D activities for orphan drugs development. However, high treatment cost, lack of approved drugs, and difficulty in patient diagnosis are some challenges restraining the market growth. Meanwhile, development of gene and cell therapies hold strong potential in offering new treatment options for Barth syndrome and thereby, present lucrative opportunities for players in the coming years. Continued efforts from industry and research organizations to better understand the pathophysiology would further expand the therapeutic options and foster the market expansion.
Key features of the study:
This report provides in-depth analysis of the global Barth syndrome treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global Barth syndrome treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Agios Pharmaceuticals, Inc., Amicus Therapeutics, Inc., and Stealth BioTherapeutics Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global Barth syndrome treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Barth syndrome treatment market.
Detailed Segmentation:
- By Therapeutic Approaches Insights (Revenue, USD Bn, 2019 - 2031)
- Enzyme Replacement Therapy
- Gene Therapy
- Supportive Care
- Stem Cell Therapy
- Others (Small Molecule Drugs)
- By Drug Classes Insights (Revenue, USD Bn, 2019 - 2031)
- Cardiolipin Precursors
- Antioxidants
- Immunomodulators
- Antibiotics
- Dietary Supplements
- Others
- By Route Of Administration Insights (Revenue, USD Bn, 2019 - 2031)
- Oral
- Intravenous
- Others (Intramuscular and Topical)
- By End user Insights (Revenue, USD Bn, 2019 - 2031)
- Hospitals
- Specialty Clinics
- Research Institutions
- Others
- By Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Amneal Pharmaceuticals
- Boehringer Ingelheim
- Merck & Co.
- Abbott
- B Braun
- Integra LifeSciences
- Johnson & Johnson
- Medtronic
- MicroPort Scientific
- NuVasive
- Orthofix
- Perrigo Company
- Stryker
- Zimmer Biomet
- Eli Lilly and Company
- F. Hoffmann-La Roche
- Mylan
- Stealth BioTherapeutics
- Sanofi
- Pfizer
Table of Contents
1. RESEARCH OBJECTIVES AND ASSUMPTIONS
- Research Objectives
- Assumptions
- Abbreviations
2. MARKET PURVIEW
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Barth Syndrome Treatment Market, By Therapeutic Approaches
- Global Barth Syndrome Treatment Market, By Drug Classes
- Global Barth Syndrome Treatment Market, By Route of Administration
- Global Barth Syndrome Treatment Market, By End User
- Global Barth Syndrome Treatment Market, By Region
3. MARKET DYNAMICS, REGULATIONS, AND TRENDS ANALYSIS
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Barth Syndrome Treatment Market, By Therapeutic Approaches, 2024-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Enzyme Replacement Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Supportive Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Stem Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others (Small Molecule Drugs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Global Barth Syndrome Treatment Market, By Drug Classes, 2024-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Cardiolipin Precursors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Antioxidants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Immunomodulators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Dietary Supplements
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Barth Syndrome Treatment Market, By Route of Administration, 2024-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others (Intramuscular and Topical)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Barth Syndrome Treatment Market, By End-User, 2024-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Barth Syndrome Treatment Market, By Region, 2019 - 2031, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2019 - 2031, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Therapeutic Approaches, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Drug Classes, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User, 2019 - 2031, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Therapeutic Approaches, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Drug Classes, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User, 2019 - 2031, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Therapeutic Approaches, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Drug Classes, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User, 2019 - 2031, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Therapeutic Approaches, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Drug Classes, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User, 2019 - 2031, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Therapeutic Approaches, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Drug Classes, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User, 2019 - 2031, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Therapeutic Approaches, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Drug Classes, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User, 2019 - 2031, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. COMPETITIVE LANDSCAPE
- Amneal Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boehringer Ingelheim
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- B Braun
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Integra LifeSciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Medtronic
- MicroPort Scientific
- NuVasive
- Orthofix
- Perrigo Company
- Stryker
- Zimmer Biomet
- Eli Lilly and Company
- F. Hoffmann-La Roche
- Mylan
- Stealth BioTherapeutics
- Sanofi
- Pfizer
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
